12:00 AM
Mar 13, 2000
 |  BC Week In Review  |  Company News  |  Deals

Kinetek, Tyrogene Biotechnologies Inc. deal

Kinetek acquired Tyrogene Biotechnologies, a cancer company developing inhibitors of protein...

Read the full 43 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >